Undermining effector-targeted susceptibility factors to provide late blight resistance

破坏效应子靶向的易感因子以提供晚疫病抗性

基本信息

  • 批准号:
    BB/N009967/1
  • 负责人:
  • 金额:
    $ 77.31万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2016
  • 资助国家:
    英国
  • 起止时间:
    2016 至 无数据
  • 项目状态:
    已结题

项目摘要

An increasing world population and impacts of climate change place ever-greater demands on the world food supply. A major constraint to global food security is crop loss due to plant pests and diseases. With the increasing stringency of conditions under which chemicals are approved for agriculture, the choice of effective fungicides and pesticides will become more limited in the near future. Furthermore, as introgressed host resistance genes are rapidly defeated by pathogens and pests in the field, there is an urgent need to explore the development of novel, durable and sustainable means to combat crop diseases.Plants face a barrage of microbial threats and defend themselves by employing two layers of inducible defence responses. The first involves recognition by cell surface receptors of essential, widely conserved molecules (called PAMPs) that are exposed by pathogens during infection. Successful (adapted) pathogens secrete and deliver proteins called effectors to suppress these defences. The second defence layer involves recognition of effectors by immune receptors, resistance proteins, to evoke effector-triggered immunity. This project focusses on the late blight pathogen Phytophthora infestans, the major pathogen of potato and tomato, two of the world's main food crops. Amongst the weapons P. infestans has to subjugate its hosts are RXLR effectors which are delivered inside plant cells to promote susceptibility. RXLR effectors have been shown to target and suppress positive regulators of immunity. In contrast, here we present considerable unpublished information revealing the discovery of two RXLR effectors that target host susceptibility (S) factors; proteins whose activity promotes disease. One effector interacts with isoforms of plant protein phosphatase 1 (PP1), forming holoenzymes that may dephosphorylate host proteins to activate or inactivate them. The other effector interacts with NRL, member of a family of plasma membrane-associated regulators of light signalling. NRL promotes susceptibility by suppressing immunity triggered by perception of a P. infestans PAMP. S factors present very attractive opportunities to undermine infection effectively and durably. For example, whereas a resistance protein imposes a selection pressure on a pathogen to alter or lose the cognate avirulence gene to evade detection, modification or conditional removal of an S factor imposes a far more challenging selection pressure, in that the associated host protein activity is required for infection. Critically, reducing endogenous levels of these S factors (PP1c isoforms and NRL) attenuates P. infestans infection, suggesting that combined reduction of both S factors may provide a durable strategy to combat late blight.Little is understood about how S factors promote disease. It is an emerging, exciting area of plant disease research, making our proposal timely. We will provide detailed understanding of 1) the virulence targets dephosphorylated by effector-PP1c holoenzymes, and the mechanistic consequences of dephosphorylation (objective 1); and 2) the means by which NRL suppresses PAMP-triggered immunity (objective 2). It will also reveal whether natural variants exist of these S factors that cannot be targeted by the associated effectors (objective 3C), implicating evolution of S factors to evade effector-mediated exploitation. These studies will provide novel insights into negative regulation of plant immunity. They also provide novel means with which to combat plant disease, and potato blight specifically.Industry is keen to exploit understanding of S factors as a durable means to provide disease resistance. This project, with industrial partner JR Simplot, will deliver novel approaches for pathogen-inducible removal of S factors to provide late blight resistance (objectives 3A; 3B).
世界人口的增加和气候变化的影响对世界粮食供应提出了越来越大的需求。全球粮食安全的一个主要制约因素是植物病虫害造成的农作物损失。随着批准用于农业的化学品的条件越来越严格,在不久的将来,有效的杀菌剂和杀虫剂的选择将变得更加有限。此外,由于导入的寄主抗性基因在田间迅速被病原体和害虫击败,迫切需要探索新的、持久的和可持续的方法来抗击作物病害。植物面临着大量的微生物威胁,并通过两层诱导防御反应来防御自己。第一个涉及细胞表面受体对基本的、广泛保守的分子(称为PAMP)的识别,这些分子在感染期间被病原体暴露。成功的(适应的)病原体分泌和传递被称为效应器的蛋白质来抑制这些防御。第二层防御层涉及免疫受体识别效应器,即抗性蛋白,以唤起效应器触发的免疫。该项目的重点是晚疫病菌,马铃薯和番茄这两种世界主要粮食作物的主要病原菌。在致病疫霉必须征服其宿主的武器中,RXLR效应器是在植物细胞内传递的,以促进敏感性。RXLR效应器已被证明可以靶向和抑制积极的免疫调节因子。相反,我们在这里展示了大量未发表的信息,揭示了两个针对宿主易感性因子(S)的RXLR效应器的发现;这些蛋白质的活性促进了疾病的发生。一个效应器与植物蛋白磷酸酶1(PP1)的异构体相互作用,形成全酶,可以使宿主蛋白去磷酸化,激活或灭活它们。另一个效应器与NRL相互作用,NRL是与质膜相关的光信号调节家族的成员。NRL通过抑制对致病疫霉PAMP的感知而触发的免疫增强易感性。S因子提供了非常有吸引力的机会,可以有效和持久地削弱感染。例如,抗性蛋白对病原菌施加选择压力以改变或丢失同源无毒基因以逃避检测、修饰或有条件地移除S因子施加更具挑战性的选择压力,因为相关的宿主蛋白活性是感染所必需的。关键是,降低这些S因子(PP1c亚型和NRL)的内源水平可以减轻致病疫霉的侵染,这表明联合减少两种S因子可能提供抗晚疫病的持久策略。关于S因子如何促进疾病尚不清楚。这是一个新兴的、令人兴奋的植物病害研究领域,使我们的建议来得及时。我们将详细了解1)由效应器-PP1c全酶去磷酸化的毒力靶标,以及去磷酸化的机制后果(目标1);以及2)NRL抑制PAMP触发的免疫(目标2)的方法。它还将揭示这些S因子是否存在不能被相关效应器靶向的自然变体(目标3C),暗示S因子的进化以逃避效应器介导的利用。这些研究将为植物免疫的负调控提供新的见解。它们还提供了对抗植物病害,特别是马铃薯枯萎病的新方法。工业界热衷于利用对S因素的了解,作为提供抗病能力的持久手段。该项目与工业合作伙伴JR Simplot合作,将提供病原体诱导去除S因子的新方法,以提供对晚疫病的抗性(目标3A;3B)。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Message in a Bubble: Shuttling Small RNAs and Proteins Between Cells and Interacting Organisms Using Extracellular Vesicles.
气泡中的消息:使用细胞外囊泡在细胞和相互作用的生物之间穿梭小RNA和蛋白质。
  • DOI:
    10.1146/annurev-arplant-081720-010616
  • 发表时间:
    2021-06-17
  • 期刊:
  • 影响因子:
    23.9
  • 作者:
    Cai Q;He B;Wang S;Fletcher S;Niu D;Mitter N;Birch PRJ;Jin H
  • 通讯作者:
    Jin H
Opening the Effector Protein Toolbox for Plant-Parasitic Cyst Nematode Interactions.
  • DOI:
    10.1016/j.molp.2016.09.008
  • 发表时间:
    2016-11-07
  • 期刊:
  • 影响因子:
    27.5
  • 作者:
    Eves-van den Akker, Sebastian;Birch, Paul R. J.
  • 通讯作者:
    Birch, Paul R. J.
All Roads Lead to Susceptibility: The Many Modes of Action of Fungal and Oomycete Intracellular Effectors.
所有道路都会引起敏感性:真菌和卵菌的细胞内效应子的许多作用方式。
  • DOI:
    10.1016/j.xplc.2020.100050
  • 发表时间:
    2020-07-13
  • 期刊:
  • 影响因子:
    10.5
  • 作者:
    He Q;McLellan H;Boevink PC;Birch PRJ
  • 通讯作者:
    Birch PRJ
Devastating intimacy: the cell biology of plant-Phytophthora interactions.
  • DOI:
    10.1111/nph.16650
  • 发表时间:
    2020-10
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Boevink PC;Birch PRJ;Turnbull D;Whisson SC
  • 通讯作者:
    Whisson SC
Plant pathogen effector utilizes host susceptibility factor NRL1 to degrade the immune regulator SWAP70.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul Birch其他文献

Target Value-Tailored Apheresis Can Improve Prediction of Product Hematopoietic Progenitor Cells Prior to Autologous Transplantation
  • DOI:
    10.1016/j.bbmt.2013.12.174
  • 发表时间:
    2014-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dawn Sheppard;Jason Tay;Lothar Huebsch;Sheryl Ann McDiarmid;Lisa Gilliard Martin;Doug Palmer;Paul Birch;Anargyros Xenocostas;Linda Hamelin;Christopher N. Bredeson
  • 通讯作者:
    Christopher N. Bredeson
Improved Prediction of CD34<sup>+</sup> Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value–Tailored Approach
  • DOI:
    10.1016/j.bbmt.2015.11.016
  • 发表时间:
    2016-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dawn Sheppard;Jason Tay;Douglas Palmer;Anargyros Xenocostas;Christina Doulaverakis;Lothar Huebsch;Sheryl McDiarmid;Alan Tinmouth;Ranjeeta Mallick;Lisa Martin;Paul Birch;Linda Hamelin;David Allan;Christopher Bredeson
  • 通讯作者:
    Christopher Bredeson

Paul Birch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul Birch', 18)}}的其他基金

MARVEL-ous Extracellular vesicles carry RXLR effectors into host plant cells
MARVEL-ous 细胞外囊泡携带 RXLR 效应子进入宿主植物细胞
  • 批准号:
    BB/Y002067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
Phosphatidylinositides defining effector protein delivery in Phytophthora
磷脂酰肌醇定义了疫霉菌中效应蛋白的传递
  • 批准号:
    BB/X014800/1
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
New Zealand partnering award: Pathogenesis and effector delivery in Phytophthora infections of woody host plants
新西兰合作奖:木本宿主植物疫霉感染的发病机制和效应物传递
  • 批准号:
    BB/T020164/1
  • 财政年份:
    2021
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
The roles of extracellular vesicle transport in late blight disease development
细胞外囊泡运输在晚疫病发展中的作用
  • 批准号:
    BB/S003096/1
  • 财政年份:
    2019
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
Defining and deploying Rpi gene diversity in S. americanum to control late blight in potato
定义和部署美洲美洲蝽 Rpi 基因多样性以控制马铃薯晚疫病
  • 批准号:
    BB/P019595/1
  • 财政年份:
    2018
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
New approaches to undermine late blight disease by exploiting an understanding of ubiquitin E3 ligases that positively regulate immunity
利用对积极调节免疫的泛素 E3 连接酶的了解,开发出消灭晚疫病的新方法
  • 批准号:
    BB/P020569/1
  • 财政年份:
    2017
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
UK-China partnership to develop durable late blight disease resistance in potato
中英合作开发马铃薯持久的晚疫病抗性
  • 批准号:
    BB/L026880/1
  • 财政年份:
    2014
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
Controlling important diseases in potato by cloning functional NB-LRR-type resistance genes
克隆功能性NB-LRR型抗性基因防治马铃薯重要病害
  • 批准号:
    BB/L01050X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
The Contribution of Phytophthora effectors to host range and non-host resistance
疫霉效应子对寄主范围和非寄主抗性的贡献
  • 批准号:
    BB/K018183/1
  • 财政年份:
    2013
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant
An enduring pipeline to identify and utilize durable late blight disease resistance in potato
识别和利用马铃薯持久晚疫病抗性的持久管道
  • 批准号:
    BB/H018697/1
  • 财政年份:
    2011
  • 资助金额:
    $ 77.31万
  • 项目类别:
    Research Grant

相似国自然基金

口腔癌前病损转化微环境中IL-1β介导Treg/ T Effector免疫失衡的功能及机制
  • 批准号:
    81600878
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
  • 批准号:
    10638364
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Modulating the immuno-metabolic interplay in liver cancer with cryoablation
通过冷冻消融调节肝癌的免疫代谢相互作用
  • 批准号:
    10647494
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
  • 批准号:
    10668167
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
阐明人星形胶质细胞中 APOE4 诱导的内溶酶体运输失调
  • 批准号:
    10670573
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
  • 批准号:
    10753211
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
用于治疗侵袭性癌症的双重作用免疫刺激纳米颗粒
  • 批准号:
    10618487
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
针对创伤引起的免疫失调中训练有素的免疫力
  • 批准号:
    10714384
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
精氨酸消耗联合铂类紫杉烷化疗对侵袭性变异前列腺癌 (AVPC) 的影响
  • 批准号:
    10715329
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Single-cell Proteogenomic profiling of HIV-1 reservoir cells
HIV-1 储存细胞的单细胞蛋白质组学分析
  • 批准号:
    10675812
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
Novel therapeutic intervention of early-stage T1D
早期 T1D 的新型治疗干预
  • 批准号:
    10698534
  • 财政年份:
    2023
  • 资助金额:
    $ 77.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了